Caris Cash from 2010 to 2026

CAI Stock  USD 25.00  0.55  2.15%   
Caris Life's Cash is increasing with slightly volatile movements from year to year. Cash is predicted to flatten to about 38.8 M. Cash is the total amount of money in the form of currency that Caris Life Sciences has in its possession. This includes all bills, coins, and funds in bank accounts. View All Fundamentals
 
Cash  
First Reported
2006-12-31
Previous Quarter
718.9 M
Current Value
753.2 M
Quarterly Volatility
125.7 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Caris Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Caris Life's main balance sheet or income statement drivers, such as Depreciation And Amortization of 61.8 M, Interest Expense of 33.1 M or Total Revenue of 497.8 M, as well as many indicators such as Price To Sales Ratio of 16.34, Dividend Yield of 0.0333 or Days Sales Outstanding of 175. Caris financial statements analysis is a perfect complement when working with Caris Life Valuation or Volatility modules.
  
Build AI portfolio with Caris Stock
Check out the analysis of Caris Life Correlation against competitors.

Latest Caris Life's Cash Growth Pattern

Below is the plot of the Cash of Caris Life Sciences over the last few years. Cash refers to the most liquid asset of Caris Life Sciences, which is listed under current asset account on Caris Life Sciences balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Caris Life customers. The amounts must be unrestricted with restricted cash listed in a different Caris Life account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. Caris Life's Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Caris Life's overall financial position and show how it may be relating to other accounts over time.
Cash10 Years Trend
Slightly volatile
   Cash   
       Timeline  

Caris Cash Regression Statistics

Arithmetic Mean50,657,230
Geometric Mean40,737,180
Coefficient Of Variation54.68
Mean Deviation19,169,372
Median46,464,000
Standard Deviation27,698,973
Sample Variance767.2T
Range103.8M
R-Value0.64
Mean Square Error482.3T
R-Squared0.41
Significance0.01
Slope3,515,338
Total Sum of Squares12275.7T

Caris Cash History

202638.8 M
202573.5 M
202464 M
202356.4 M
2021107.2 M
202053.5 M
201946.5 M

Other Fundumenentals of Caris Life Sciences

Caris Life Cash component correlations

About Caris Life Financial Statements

Investors use fundamental indicators, such as Caris Life's Cash, to determine how well the company is positioned to perform in the future. Although Caris Life's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.

Currently Active Assets on Macroaxis

When determining whether Caris Life Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Caris Life's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Caris Life Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Caris Life Sciences Stock:
Check out the analysis of Caris Life Correlation against competitors.
You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Is Trading Companies & Distributors space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Caris Life. If investors know Caris will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Caris Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.25)
Revenue Per Share
3.18
Quarterly Revenue Growth
0.499
The market value of Caris Life Sciences is measured differently than its book value, which is the value of Caris that is recorded on the company's balance sheet. Investors also form their own opinion of Caris Life's value that differs from its market value or its book value, called intrinsic value, which is Caris Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Caris Life's market value can be influenced by many factors that don't directly affect Caris Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Caris Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Caris Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Caris Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.